🦊/Lists

Biotech Investors & VC Firms in United States

1265 firms in this list, with a median first check of $500K. 278 of them lead rounds. Generated from verified public data and updated continuously.

OVNI Capital
San FranciscoPre-Seed–Series A$250K – $2M
11 people
OSF Ventures
PeoriaSeed–Series A
19 people
E2MC Ventures
OrlandoPre-Seed–Late Stage$250K – $2M
16 people
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage$20M – $80M
18 people
GRA Venture
GeorgiaSeed–Series A
20 people
Boost VC
San MateoPre-Seed–Seed$500K
10 people
Dellin Investments
PhiladelphiaPre-Seed–Growth
7 people
J2 Ventures
BostonPre-Seed–Series A
19 people
Cure Ventures
BostonPre-Seed–Series A
22 people
Future Ventures
Los AltosPre-Seed–Series A$1M – $10M
4 people
Takeda Ventures
CambridgePre-Seed–Late Stage$1M – $5M
19 people
KdT Ventures
AustinPre-Seed–Series A$500K – $3M
9 people
FoundersX Ventures
Silicon ValleyPre-Seed–Series A
14 people
Remiges Ventures, Inc.
SeattlePre-Seed–Seed
22 people
Able Partners
New YorkPre-Seed–Series A$500K – $3M
3 people
Start Codon
CambridgePre-Seed–Seed
24 people
Delos Capital
CambridgeSeed–Late Stage
17 people
Neotribe Ventures
Menlo ParkPre-Seed–Growth$250K – $2M
5 people
Oberland Capital
New YorkGrowth–Late Stage$50M – $300M
20 people
Flagship Pioneering
CambridgeSeed–Series A$500K – $10M
7 people
Innova Memphis, Inc.
MemphisPre-Seed–Series A$2M
4 people
MassVentures
WalthamPre-Seed–Late Stage$250K – $500K
10 people
Breakout Ventures
San FranciscoSeed–Series B$500K – $6M
15 people
Ajax Health
Menlo ParkSeed–Late Stage
26 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.